Rafferty Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $149K | Sell |
54,545
-6,500
| -11% | -$20.6K | ﹤0.01% | 1037 |
|
|
2025
Q4 | $226K | Buy |
61,045
+32,794
| +116% | +$106K | ﹤0.01% | 1067 |
|
|
2025
Q3 | $74.9K | Buy |
+28,251
| New | +$54.6K | ﹤0.01% | 1102 |
|
|
2025
Q2 | – | Sell |
-40,608
| Closed | -$58.5K | – | 1085 |
|
|
2025
Q1 | $58.5K | Buy |
40,608
+3,552
| +10% | +$6.54K | ﹤0.01% | 1054 |
|
|
2024
Q4 | $81.5K | Buy |
+37,056
| New | +$86.5K | ﹤0.01% | 1131 |
|
|
2023
Q2 | – | Sell |
-13,287
| Closed | -$21.1K | – | 1106 |
|
|
2023
Q1 | $21.1K | Buy |
13,287
+2,396
| +22% | +$12.4K | ﹤0.01% | 1138 |
|
|
2022
Q4 | $67.9K | Buy |
+10,891
| New | +$77.9K | ﹤0.01% | 1115 |
|
|
2022
Q1 | – | Sell |
-34,327
| Closed | -$172K | – | 1252 |
|
|
2021
Q4 | $172K | Buy |
+34,327
| New | +$275K | ﹤0.01% | 1237 |
|
|
2021
Q3 | – | Sell |
-98,918
| Closed | -$2.09M | – | 1278 |
|
|
2021
Q2 | $2.09M | Sell |
98,918
-10,897
| -10% | -$262K | 0.01% | 674 |
|
|
2021
Q1 | $3.08M | Buy |
109,815
+79,954
| +268% | +$2.36M | 0.02% | 471 |
|
|
2020
Q4 | $776K | Sell |
29,861
-22,575
| -43% | -$676K | 0.01% | 579 |
|
|
2020
Q3 | $1.95M | Buy |
52,436
+30,476
| +139% | +$1.21M | 0.02% | 424 |
|
|
2020
Q2 | $1.13M | Buy |
+21,960
| New | +$919K | 0.02% | 509 |
|
|
2020
Q1 | – | Sell |
-31,356
| Closed | -$1.87M | – | 668 |
|
|
2019
Q4 | $1.87M | Sell |
31,356
-63,078
| -67% | -$2.84M | 0.03% | 410 |
|
|
2019
Q3 | $3.46M | Buy |
94,434
+1,175
| +1% | +$46.5K | 0.05% | 203 |
|
|
2019
Q2 | $4.34M | Buy |
93,259
+24,489
| +36% | +$1.15M | 0.08% | 193 |
|
|
2019
Q1 | $2.76M | Buy |
+68,770
| New | +$3.08M | 0.04% | 252 |
|
Other funds holding ESPR
WA
TSC
O
VCM
